DRL Eyes Europe's Biosimilar Market
  • Prabha Hedge
  • Dec 12 2013

December 12: Dr. Reddy's is betting big on biosimilars. The pharma giant is tying up with Germany's Merck to launch cheaper versions of cancer drug in the European market. Bloomberg TV India’s Agam Vakil shares a detailed report.